Attenuation of the epithelial-to-mesenchymal transition (EMT) and inhibition of EGFR/p-AKT signaling may be the mechanisms underlying the tumor-suppressive role of miR-424 in bladder cancer. Here, AKT1 is linked to urinary bladder cancer.